Search results for "pine"

showing 10 items of 2022 documents

Is Activation of the Back Muscles Impaired by Creep or Muscle Fatigue?

2010

STUDY DESIGN: Intervention study on healthy human subjects. OBJECTIVE: To determine whether reflex activation of the back muscles is influenced by muscle fatigue or soft tissue creep in the spine. SUMMARY OF BACKGROUND DATA: Reflex contraction of the back muscles normally acts to limit spinal flexion, and hence protect the underlying spine from injury. However, repeated flexion allows bending moments on the spine to increase. Impaired reflexes as a result of fatigue or soft tissue creep may be contributing factors. METHODS: A total of 15 healthy volunteers (8 females/7 males aged 23-55 years) underwent 2 interventions, on separate days: (a) sitting flexed for 1 hour to induce creep and (b) …

AdultMalePostureElectromyographyCentral nervous system diseaseLumbarmedicineHumansOrthopedics and Sports MedicineRange of Motion ArticularMuscle SkeletalAnalysis of VarianceBackmedicine.diagnostic_testMuscle fatigueElectromyographybusiness.industrySoft tissueRepeated measures designAnatomyMiddle Agedmedicine.diseaseSpineAnesthesiaMuscle FatigueReflexFemaleNeurology (clinical)medicine.symptombusinessMuscle ContractionMuscle contractionSpine
researchProduct

Savoxepine: invalidation of an "atypical" neuroleptic response pattern predicted by animal models in an open clinical trial with schizophrenic patien…

1991

The new tetracyclic compound savoxepine exhibits potent antidopaminergic effects with preferential activity in the hippocampus as compared to striatum in rat brain. As a result of behavioural animal models and regional differences in dopamine receptor binding characteristics, it has been suggested to possess an "atypical" neuroleptic response pattern. In an open clinical trial, savoxepine was administered to 12 in-patients suffering from paranoid schizophrenia and schizophreniform disorder (DSM-III). Eight patients were treated with a stable dose of 0.5 mg per day throughout the study, while in the remaining patients higher doses up to 20 mg/day were administered. Mean total BPRS scores and…

AdultMalePsychosisParanoid schizophreniamedicine.medical_treatmentPharmacologyExtrapyramidal symptomsBasal Ganglia DiseasesmedicineHumansSchizophreniform disorderAntipsychoticAgedPharmacologyPsychiatric Status Rating ScalesDopamine antagonistDopamine receptor bindingMiddle Agedmedicine.diseaseEnzymesDisease Models AnimalSchizophreniaDibenzoxazepinesSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychologymedicine.drugAntipsychotic AgentsPsychopharmacology
researchProduct

Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and cha…

1995

Preclinical data indicated that seroquel (ICI 204 636), a dibenzothiazepine with 5-HT2 and D2-like receptor antagonistic properties, might be an effective antipsychotic agent, causing fewer extrapyramidal side effects than typical neuroleptics. In the present study, 12 patients suffering from schizophrenia or schizophreniform disorder with predominantly positive symptomatology were treated in an open clinical trial for 4 weeks with seroquel at a maximum dosage of 750 mg/day. The drug was generally well tolerated, and virtually no adverse extrapyramidal side effects such as acute dystonia, parkinsonism or akathisia were observed. Total scores for BPRS (item score 0–6; baseline: 42.0±2.3; mea…

AdultMalePsychosismedicine.medical_specialtyDibenzothiazepinesTime Factorsmedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticThyrotropinAkathisiaGastroenterologyQuetiapine FumarateAntipsychotic AgentInternal medicinemedicineHumansSchizophreniform disorderAntipsychoticAgedPharmacologyPsychiatric Status Rating ScalesParkinsonismElectroencephalographyMiddle Agedmedicine.diseaseProlactinTreatment OutcomeSchizophreniaAnesthesiaSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychologyAntipsychotic AgentsPsychopharmacology
researchProduct

The prevalence of sleep impairments and predictors of sleep quality among patients with asthma

2020

Background: Sleep is a significant dimension of daily life. However, only a few studies have examined the sleep quality of asthmatics in a real-world clinical settings. Objective: This study is aimed to estimate the prevalence of sleep impairments among asthmatic patients and examine the relationship between sleep quality, asthma control, rhinitis symptoms, and sociodemographic characteristics. Methods: The present study adopted the observational cross-sectional research design that has been designed by the Italian Respiratory Society and used valid assessments to measure the study variables. Results: Data from 1150 asthmatic patients (mean age 51.01 years ± 16.03) were subjected to analysi…

AdultMalePulmonary and Respiratory Medicineasthma; quality of life; reflux; rhinitis; sleep; sleepiness;Settore MED/09 - Medicina InternaCross-sectional studySettore MED/10 - Malattie Dell'Apparato RespiratoriosleepinessQuality of life (healthcare)rhinitisSleep Initiation and Maintenance DisordersPrevalencemedicineHumansImmunology and AllergysleepAgedAsthmaAsthma quality of life reflux rhinitis sleep sleepinessSleep Apnea ObstructiveSleep qualitybusiness.industryMiddle Agedmedicine.diseaseSleep in non-human animalsAsthma; quality of life; reflux; rhinitis; sleep; sleepinessAsthmarhinitiasthma sleep rhinitis sleepiness reflux quality of lifeCross-Sectional StudiesSocioeconomic Factorsquality of lifePediatrics Perinatology and Child HealthGastroesophageal RefluxFemaleSettore MED/26 - NeurologiarefluxbusinessClinical psychology
researchProduct

Vasopressin receptors involved in adrenergic neurotransmission in the circular muscle of the human vas deferens

1998

We studied the effects of vasopressin on the adrenergic responses of in vitro preparations of circular muscle from the vas deferens obtained from 28 men undergoing elective vasectomy. Vasopressin (3 x 10(-9)-3 x 10(-8) M) enhanced the phasic contractions elicited by electrical field stimulation and noradrenaline. This potentiation was blocked by the vasopressin V1 receptor antagonist d(CH2)5Tyr(Me)vasopressin (10(-6) M) but not by the vasopressin V2 receptor antagonist [d(CH2)5, D-Ile2,Ile4,Arg8]vasopressin (10(-6) M). The Ca2+ antagonist nifedipine (10(-6) M) did not affect the potentiation of electrical field stimulation induced by vasopressin and noradrenaline but reduced KCl-induced con…

AdultMaleReceptors Vasopressinmedicine.medical_specialtyVasopressinNifedipineVasopressinsNeuropeptideAdrenergicStimulationIn Vitro TechniquesSynaptic TransmissionPotassium ChlorideNorepinephrineHormone AntagonistsVas DeferensInternal medicinemedicineHumansVasoconstrictor AgentsVasopressin receptorPharmacologyArginine vasopressin receptor 1BChemistryAntagonistVas deferensMuscle SmoothCalcium Channel BlockersElectric StimulationArginine Vasopressinmedicine.anatomical_structureEndocrinologyAdrenergic alpha-AgonistsAntidiuretic Hormone Receptor Antagonistshormones hormone substitutes and hormone antagonistsMuscle ContractionEuropean Journal of Pharmacology
researchProduct

Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine

2002

It has been proposed that norepinephrine plays a critical role in the modulation of cortical excitability, which in turn is thought to influence functional recovery from brain lesions. The purpose of the present experiments was to determine if it is possible to modulate cortical excitability with the selective norepinephrine reuptake inhibitor reboxetine in intact humans. Recruitment curve and intracortical facilitation, assessed by transcranial magnetic stimulation, were increased after oral intake of 8 and 4 mg reboxetine, in the absence of changes in motor threshold, intracortical inhibition, M-response, F-wave or H-reflex. These results demonstrate that reboxetine enhances cortical exci…

AdultMaleRecruitment NeurophysiologicalMorpholinesmedicine.medical_treatmentCentral nervous systemNorepinephrine (medication)MagneticsReboxetinemedicineHumansNeurorehabilitationAdrenergic Uptake InhibitorsElectromyographyGeneral NeuroscienceReboxetineMotor CortexNeural InhibitionEvoked Potentials MotorTranscranial magnetic stimulationmedicine.anatomical_structureCatecholamineReuptake inhibitorPsychologyNeuroscienceMotor cortexmedicine.drugNeuroscience Letters
researchProduct

Reoperation Rates Following Instrumented Lumbar Spine Fusion

2018

Study Design. A prospective cohort study. Objective. This study evaluated the cumulative reoperation rate and indications for reoperation following instrumented lumbar spine fusion (LSF). Summary of Background Data. LSF reduces disability and improves health-related quality of life for patients with several spinal disorders. The rate of instrumented LSF has drastically increased over the last few decades. The increased incidence of LSF, however, has led to increased reoperation rates. Methods. The data are based on the prospective LSF database of Tampere University Hospital that includes all elective indications for LSF surgery. A total of 433 consecutive patients (64% women, mean age 62 ye…

AdultMaleReoperationmedicine.medical_specialtycomplicationssurgical treatmentmedicine.medical_treatmentreoperationadjacent segmentKaplan-Meier EstimateleikkaushoitolannerankaYoung Adult03 medical and health sciences0302 clinical medicineQuality of lifeHumansMedicineOrthopedics and Sports MedicineCumulative incidenceProspective StudiesTreatment Failure030212 general & internal medicineYoung adultortopediaProspective cohort studySurvival rateAgedta3126Aged 80 and overinstrumented lumbar spine fusionLumbar Vertebraebusiness.industryIncidence (epidemiology)ta3141komplikaatiotMiddle AgedConfidence intervalProsthesis FailureSurgerySpinal FusionSpinal fusionorthopedicsFemaleSpinal DiseasesNeurology (clinical)business030217 neurology & neurosurgerySpine
researchProduct

The Decreasing Prevalence of the Arcuate Foramen

2018

[Background]: The arcuate foramen (AF), or ponticulus posticus, is an anatomic variant of the first cervical vertebra that consists of a complete or partial osseous bridge over the groove for the vertebral artery and extends from the posterior aspect of the superior articular facet to the superior lateral border of the posterior arch. The AF has been associated with clinical symptoms, such as headache, migraine, neck pain, shoulder pain, arm pain, and vertebral artery dissection. We aimed to test whether the prevalence of the AF has decreased in the modern human population over the past centuries as a result of reduction in inbreeding and endogamy.

AdultMaleRural Populationmusculoskeletal diseases0301 basic medicinemedicine.medical_specialtyUrban PopulationVertebral artery dissectionVertebral arteryPopulationConsanguinityYoung Adult03 medical and health sciences0302 clinical medicinemedicine.arteryHumansMedicineProspective StudiesVertebral arteryeducationSigns and symptomsAgedAged 80 and overArcuate forameneducation.field_of_studyNeck painbusiness.industryAnatomic VariationMiddle Agedmusculoskeletal systemmedicine.diseaseConfidence intervalSpineSurgeryBridge (graph theory)ArchaeologyMigraineRisk factorsCervical atlasFemaleSurgery030101 anatomy & morphologyNeurology (clinical)medicine.symptomAnatomybusiness030217 neurology & neurosurgery
researchProduct

Daily eudaimonic well-being as a predictor of daily performance: A dynamic lens.

2019

Sustaining employees' well-being and high performance at work is a challenge for organizations in today's highly competitive environment. This study examines the dynamic reciprocal relationship between the variability in office workers' eudaimonic well-being (i.e., activity worthwhileness) and their extra-role performance. Eighty-three white-collar employees filled in a diary questionnaire twice a day, once in the morning and once in the afternoon, on four consecutive working days. The results show that eudaimonic well-being displays clear variability in a short time frame. In addition, Bayesian Multilevel Structural Equation Models (MSEMs) reveal a significant positive relationship between…

AdultMaleSATISFACTIONmedia_common.quotation_subjectScienceHappiness050109 social psychologyEfficiencyGOALSORGANIZATIONAL CITIZENSHIPJob SatisfactionStructural equation modelingDevelopmental psychologySurveys and Questionnaires0502 economics and businessHumans0501 psychology and cognitive sciencesWorkplaceWORK-ENGAGEMENTWork PerformanceSelf-determination theoryMorningmedia_commonOrganizational citizenship behaviorMultidisciplinaryScience & TechnologyWork engagement05 social sciencesQSELF-DETERMINATION THEORYRBayes TheoremMOTIVATIONMiddle AgedDAILY DIARYMultidisciplinary SciencesJOB CHARACTERISTICSINTRAINDIVIDUAL VARIABILITY8. Economic growthWell-beingHappinessScience & Technology - Other TopicsMedicineFemaleJob satisfactionEMPLOYEESPsychology050203 business & managementPLoS ONE
researchProduct

Comparison of the anticonstrictor action of dihydropyridines (nimodipine and nicardipine) and Mg2+ in isolated human cerebral arteries.

1992

The isometric tension recorded from ring segments of branches of human middle cerebral artery was the parameter used to study the inhibition of spasmogen-induced contractions as model for cerebral vasospasm. Concentration-response curves to 5-hydroxytryptamine (10(-9)-3 x 10(-5) M) and prostaglandin F2 alpha (10(-7)-3 x 10(-5) M) were inhibited in Ca(2+)-free medium and in Ca(2+)-free medium to which EGTA (1 mM) had been added, respectively. Nimodipine (10(-7), 10(-5) M), nicardipine (10(-7), 10(-5) M) and Mg2+ (magnesium sulfate 10(-4), 10(-2) M) inhibited the 5-HT-elicited contractions, and this inhibition was similar for the highest concentrations tested. In contrast, nimodipine and nica…

AdultMaleSerotoninNicardipineCerebral arteriesProstaglandinPharmacologyIn Vitro TechniquesDinoprostchemistry.chemical_compoundNicardipineCerebral vasospasmmedicine.arterymedicineHumansMagnesiumNimodipineAgedPharmacologyAged 80 and overChemistryCerebral ArteriesMiddle AgedEGTAIschemic Attack TransientVasoconstrictionAnesthesiaMiddle cerebral arteryCirculatory systemCalciumFemaleNimodipinemedicine.drugEuropean journal of pharmacology
researchProduct